Resonance Health is an Australian MedTech leader specialising in the development and commercialisation of non-invasive medical imaging analysis technologies. With a focus on Core Lab and AI-powered products, the company assists clinicians and radiologists in the diagnosis and management of patients across various clinical settings. Its flagship product, FerriScan®, launched in 2005, offers precise liver iron concentration assessments essential for managing conditions like Thalassaemia and other iron overload related diseases.
Expanding beyond its Core Lab offerings, Resonance Health has developed AI solutions such as FerriSmart® and HepaFatSmart® for comprehensive liver health evaluations. These innovations, alongside research tools and calibration products for MRI machine accuracy, reinforce the company's commitment to advancing medical research and diagnostics. Resonance Health also provides extensive imaging services for global clinical trials, positioning itself as a key contributor to the medical diagnostics and research community.